Nova End Period Cash Flow from 2010 to 2024

Stocks . Australia . 
Stock . Nova Eye Medical
EYE Stock   0.15  0.01  6.25%   
Nova Eye End Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. End Period Cash Flow is likely to outpace its year average in 2024. From the period from 2010 to 2024, Nova Eye End Period Cash Flow quarterly data regression had mean square error of 566.5 T and mean deviation of  13,014,387. View All Fundamentals
 
End Period Cash Flow  
First Reported
1991-09-30
Previous Quarter
2.6 M
Current Value
6.2 M
Quarterly Volatility
10.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nova Eye financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nova Eye's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Interest Expense of 66.5 K or Selling General Administrative of 12.4 M, as well as many indicators such as . Nova financial statements analysis is a perfect complement when working with Nova Eye Valuation or Volatility modules.
  
This module can also supplement various Nova Eye Technical models . Check out the analysis of Nova Eye Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Nova Stock Analysis

When running Nova Eye's price analysis, check to measure Nova Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nova Eye is operating at the current time. Most of Nova Eye's value examination focuses on studying past and present price action to predict the probability of Nova Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nova Eye's price. Additionally, you may evaluate how the addition of Nova Eye to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY